Two Decades of Liver Transplants for Primary Biliary Cholangitis: A Comparative Study of Living Donors vs. Deceased Donor Liver Transplantations
Journal of Clinical Medicine · 15.10.2023 · 12 (20) · 6536
DOI: 10.3390/jcm12206536 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 15.10.2023. Verfasst von Esli Medina-Morales und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ 07103, USA. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Primary biliary cholangitis (PBC) prompts liver transplantation (LT) due to cholestasis, cirrhosis, and liver failure. Despite lower MELD scores, recent studies highlight higher PBC waitlist mortality, intensifying the need for alternative transplantation strategies. Living donor liver transplant (LDLT) has emerged as a solution to the organ shortage. This study compares LDLT and deceased donor liver transplant (DDLT) outcomes in PBC patients via retrospective analysis of the UNOS database (2002–2021). Patient survival, graft failure, and predictors were evaluated through Kaplan–Meier and Cox-proportional analyses. Among 3482 DDLTs and 468 LDLTs, LDLT showed superior patient survival (92.3%, 89.1%, 87.6%, 85.0%, 77.2% vs. 91.5%, 88.3%, 86.3%, 82.2%, 71.0%; respectively; p = 0.02) with no significant graft survival difference at 1-, 2-, 3-, 5-, and 10-years post-LT (91.0%, 88.0%, 85.7%, 83.0%, 75.4% vs. 90.5%, 87.4%, 85.3%, 81.3%, 70.0%; respectively; p = 0.06). Compared to DCD, LDLT showed superior patient and graft survival (p < 0.05). Younger male PBC recipients with a high BMI, diabetes, and dialysis history were associated with mortality and graft failure (p < 0.05). Our study showed that LDLT had superior patient survival to DDLT. Predictors of poor post-LT outcomes require further validation studies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ 07103, USA.
- Division of Gastroenterology, Hepatology and Nutrition, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.
- Department of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA.
- Section of Digestive Diseases, Yale School of Medicine, New Haven, CT 06510, USA.
ORCID-Profile: Esli Medina-Morales, Leandro Sierra, Alan Bonder
Zitieren
APA
Medina-Morales, E., Ismail, M., Barba Bernal, R., Abboud, Y., Sierra, L., Marenco-Flores, A., Goyes, D., Saberi, B., Patwardhan, V., & Bonder, A. (2023). Two Decades of Liver Transplants for Primary Biliary Cholangitis: A Comparative Study of Living Donors vs. Deceased Donor Liver Transplantations. Journal of Clinical Medicine, 12(20), 6536. https://doi.org/10.3390/jcm12206536
Vancouver
Medina-Morales E, Ismail M, Barba Bernal R, Abboud Y, Sierra L, Marenco-Flores A, et al. Two Decades of Liver Transplants for Primary Biliary Cholangitis: A Comparative Study of Living Donors vs. Deceased Donor Liver Transplantations. Journal of Clinical Medicine. 2023;12(20):6536. doi:10.3390/jcm12206536
BibTeX
@article{MedinaMorales2023,
author = {Medina-Morales, Esli and Ismail, Mohamed and Barba Bernal, Romelia and Abboud, Yazan and Sierra, Leandro and Marenco-Flores, Ana and Goyes, Daniela and Saberi, Behnam and Patwardhan, Vilas and Bonder, Alan},
title = {Two Decades of Liver Transplants for Primary Biliary Cholangitis: A Comparative Study of Living Donors vs. Deceased Donor Liver Transplantations},
journal = {Journal of Clinical Medicine},
year = {2023},
volume = {12},
number = {20},
pages = {6536},
doi = {10.3390/jcm12206536}
}
EUVIMED